Wearable tech offers so much for insurers now, and in the future. Think about it, you can monitor all kinds of risk in nursing and car homes, or sheltered accom for seniors. It also offers valuable data for Life insurance brands, as people of all ages undertake various exercise regimes…or stay on the sofa watch Netflix. Then there’s rehab treatments and physio after a personal injury claim.
Here’s some news on a watch that can offer real insights;
Corsano Health, a leading MedTech company developing, producing, and marketing medical grade continuous health monitoring announced the launch of its CardioWatch 287 at MEDICA 2021. MEDICA is the world‘s largest medical marketplace annually organised in Düsseldorf, taking place this year from 15 – 18 November. Corsano’s CardioWatch 287 accuracy of a state-of-the-art bracelet has been validated in six third party clinical investigations. “The independent validations of Corsano Health’s CardioWatch 287 are important evidence to prove accurate measurement of five vital parameters. Moreover, Corsano offers access to raw PPG and ACC data for further analysis to academic researchers and contract research organizations. Corsano’s non-invasive ergonomic wearables deliver medically validated data with superior patient compliance.” said Drs. Peter Stas, CEO of Corsano Health. “Additionally, patient satisfaction surveys conducted at the closure of the studies cite convenience and ease to use of the CardioWatch 287 devices.” Due to their non-intrusive and convenient nature, wearable devices like Corsano’s CardioWatch 287 have great potential for high volume accessible long-term monitoring of at-risk patients.